Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40–CD40 ligand signaling in atherosclerosis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Increasing evidence supports involvement of inflammation and immunity in atherogenesis. We report here that CD40 ligand (CD40L), an immunoregulatory signaling molecule heretofore considered largely restricted to recently activated CD4+T lymphocytes, is expressed by human vascular endothelial cells (EC), smooth muscle cells (SMC), and human macrophages in vitro, and is coexpressed with its receptor CD40 on all three cells types in human atherosclerotic lesions in situ. Cultured human vascular EC, SMC, and human macrophages all constitutively expressed CD40L mRNA as well as protein. Stimulation with interleukin 1β, tumor necrosis factor α, or interferon γ increased surface levels and de novo synthesis of CD40L on all three cell types. CD40L expressed on EC, SMC, and macrophages exhibited biological activity, as it induced B7.2 expression on B cells. Human vascular SMC also constitutively expressed CD40, the receptor for CD40L, and through CD40 signaling, human recombinant CD40L induced expression of proinflammatory cytokines in these cells, identifying SMC as a target for CD40L. Human atherosclerotic lesions (n= 8) showed expression of immunoreactive CD40L on EC, SMC, and macrophages, while normal arterial tissues (n= 5) contained no CD40L. In atheroma CD40L+cells often also expressed CD40. These observations establish human vascular EC, SMC, and human macrophages as a novel source of CD40L, and point to T cell-independent CD40 signaling, and a broader function of this pathway in regulation of nonimmune cells, as illustrated here by potential autocrine and paracrine activation during atherogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Isolation of mononuclear cells and granulocytes from human blood.
Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 9,585
The Glomerular Permeability Determined by Dextran Clearance Using Sephadex Gel Filtration
Mogensen, C. E. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365516809076979 · Cited by 2,654
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., et al. (1996) · Nature · doi:10.1038/381434a0 · Cited by 1,455
Activation of human dendritic cells through CD40 cross-linking.
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., & Banchereau, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1263 · Cited by 1,317
Molecular and biological characterization of a murine ligand for CD40
Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., et al. (1992) · Nature · doi:10.1038/357080a0 · Cited by 1,022
Noelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A., & Aruffo, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6550 · Cited by 804
Induction of human IgE synthesis in B cells by mast cells and basophils
Gauchat, J.-F., Henchoz, S., Mazzei, G., Aubry, J.-P., Brunner, T., Blasey, H., Life, P., Talabot, D., Flores-Romo, L., Thompson, J., et al. (1993) · Nature · doi:10.1038/365340a0 · Cited by 656
Self-citationIMMUNE REGULATION BY CD40 AND ITS LIGAND GP39
Foy, T. M., Aruffo, A., Bajorath, J., Buhlmann, J. E., & Noelle, R. J. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.591 · Cited by 626
Cited by
The immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
Self-citationCD40 AND CD154 IN CELL-MEDIATED IMMUNITY
Grewal, I. S., & Flavell, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.111 · Cited by 1,539
van Kooten, C., & Banchereau, J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.2 · Cited by 1,404
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Self-citationJego, G., Palucka, A. K., Blanck, J.-P., Chalouni, C., Pascual, V., & Banchereau, J. (2003) · Immunity · doi:10.1016/s1074-7613(03)00208-5 · Cited by 1,067
“We have previously demon-activated endothelial cells (Mach et al., 1997), mast cells (Gauchat et al., 1993), platelets (Henn et al., 1998) as strated that myeloid DCs, generated by culturing CD34 hematopoietic stem cells, are able to enhance B cellwell as activated B cells themselves (Grammer et…”
BackgroundINFLAMMATION AND ATHEROSCLEROSIS
Hansson, G. K., Robertson, A.-K. L., & Söderberg-Nauclér, C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100100 · Cited by 1,046
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
Hansson, G. K., Libby, P., Schönbeck, U., & Yan, Z.-Q. (2002) · Circulation Research · doi:10.1161/01.res.0000029784.15893.10 · Cited by 1,024
Self-citationInflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925
Self-citationCTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
Kirk, A. D., Harlan, D. M., Armstrong, N. N., Davis, T. A., Dong, Y., Gray, G. S., Hong, X., Thomas, D., Fechner, J. H., & Knechtle, S. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8789 · Cited by 929
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
Mach, F., Schönbeck, U., Sukhova, G. K., Atkinson, E., & Libby, P. (1998) · Nature · doi:10.1038/28204 · Cited by 910
Self-citationImmune Mechanisms in Atherosclerosis
Hansson, G. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1201.100220 · Cited by 876
Newby, A. C. (2005) · Physiological Reviews · doi:10.1152/physrev.00048.2003 · Cited by 817
Apoptosis: Basic Mechanisms and Implications for Cardiovascular Disease
Haunstetter, A., & Izumo, S. (1998) · Circulation Research · doi:10.1161/01.res.82.11.1111 · Cited by 807
Inflammation and plaque vulnerability
Hansson, G. K., Libby, P., & Tabas, I. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12406 · Cited by 805
Self-citationInflammation in Atherosclerosis: Transition From Theory to Practice
Libby, P., Okamoto, Y., Rocha, V. Z., & Folco, E. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0706 · Cited by 799
Self-citationNew Markers of Inflammation and Endothelial Cell Activation: Part I
Szmitko, P. E., Wang, C.-H., Weisel, R. D., de Almeida, J. R., Anderson, T. J., & Verma, S. (2003) · Circulation · doi:10.1161/01.cir.0000089190.95415.9f · Cited by 738
The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
Schönbeck*RID="*"ID="*" Correspondi, U., & Libby, P. (2001) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000776 · Cited by 737
Self-citationSugiyama, S., Okada, Y., Sukhova, G. K., Virmani, R., Heinecke, J. W., & Libby, P. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64036-9 · Cited by 699
Self-citationInnate and acquired immunity in atherogenesis
Binder, C. J., Chang, M.-K., Shaw, P. X., Miller, Y. I., Hartvigsen, K., Dewan, A., & Witztum, J. L. (2002) · Nature Medicine · doi:10.1038/nm1102-1218 · Cited by 642
Interleukin-1 Beta as a Target for Atherosclerosis Therapy
Libby, P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.028 · Cited by 619
Self-citationAutoimmune disease: why and where it occurs
Marrack, P., Kappler, J., & Kotzin, B. L. (2001) · Nature Medicine · doi:10.1038/90935 · Cited by 609
Inflammation and Thrombosis: The Clot Thickens
Libby, P., & Simon, D. I. (2001) · Circulation · doi:10.1161/01.cir.103.13.1718 · Cited by 605
Self-citationInflammatory Mechanisms: The Molecular Basis of Inflammation and Disease
Libby, P. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00352.x · Cited by 596
Self-citationCD40 Signaling and Plaque Instability
Schönbeck, U., & Libby, P. (2001) · Circulation Research · doi:10.1161/hh2401.101272 · Cited by 566
Self-citationImmune mechanisms in atherosclerosis.
Hansson, G. K., Jonasson, L., Seifert, P. S., & Stemme, S. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.567 · Cited by 515
Aukrust, P., Müller, F., Ueland, T., Berget, T., Aaser, E., Brunsvig, A., Solum, N. O., Forfang, K., Frøland, S. S., & Gullestad, L. (1999) · Circulation · doi:10.1161/01.cir.100.6.614 · Cited by 506
Chemokines and atherosclerosis
Reape, T. J., & Groot, P. H. E. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00346-9 · Cited by 504
Mach, F., Schönbeck, U., Bonnefoy, J.-Y., Pober, J. S., & Libby, P. (1997) · Circulation · doi:10.1161/01.cir.96.2.396 · Cited by 493
Self-citationMach, F., Sauty, A., Iarossi, A. S., Sukhova, G. K., Neote, K., Libby, P., & Luster, A. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6993 · Cited by 464
Self-citationSoluble CD40L and Cardiovascular Risk in Women
Schönbeck, U., Varo, N., Libby, P., Buring, J., & Ridker, P. M. (2001) · Circulation · doi:10.1161/hc4401.099447 · Cited by 459
Self-citationDisruption of TGF-β signaling in T cells accelerates atherosclerosis
Robertson, A.-K. L., Rudling, M., Zhou, X., Gorelik, L., Flavell, R. A., & Hansson, G. K. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18607 · Cited by 441
Requirement for CD154 in the progression of atherosclerosis
Lutgens, E., Gorelik, L., Daemen, M. J. A. P., de Muinck, E. D., Grewal, I. S., Koteliansky, V. E., & Flavell, R. A. (1999) · Nature Medicine · doi:10.1038/15271 · Cited by 439
Autoimmune and Inflammatory Mechanisms in Atherosclerosis
Wick, G., Knoflach, M., & Xu, Q. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104644 · Cited by 431
Role of Inflammation in Atherosclerosis Associated with Rheumatoid Arthritis
Libby, P. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.06.014 · Cited by 413
Self-citationRole of Monocytes in Atherogenesis
ØSTERUD, B., & BJØRKLID, E. (2003) · Physiological Reviews · doi:10.1152/physrev.00005.2003 · Cited by 412
Interleukin-10 Blocks Atherosclerotic Events In Vitro and In Vivo
Pinderski Oslund, L. J., Hedrick, C. C., Olvera, T., Hagenbaugh, A., Territo, M., Berliner, J. A., & Fyfe, A. I. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.12.2847 · Cited by 396
Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions
Schönbeck, U., Sukhova, G. K., Graber, P., Coulter, S., & Libby, P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65230-3 · Cited by 379
Self-citationInflammation in atherosclerosis
Taleb, S. (2016) · Archives of Cardiovascular Diseases · doi:10.1016/j.acvd.2016.04.002 · Cited by 375
Vascular biology of atherosclerosis: overview and state of the art
Libby, P. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03143-0 · Cited by 361
Self-citationInhibition of CD40 signaling limits evolution of established atherosclerosis in mice
Schönbeck, U., Sukhova, G. K., Shimizu, K., Mach, F., & Libby, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7458 · Cited by 356
Self-citationMicroglial Activation Resulting from CD40-CD40L Interaction After β-Amyloid Stimulation
Tan, J., Town, T., Paris, D., Mori, T., Suo, Z., Crawford, F., Mattson, M. P., Flavell, R. A., & Mullan, M. (1999) · Science · doi:10.1126/science.286.5448.2352 · Cited by 352
Krishnaswamy, G., Kelley, J., Yerra, L., Smith, J. K., & Chi, D. S. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099314234 · Cited by 341
Kalunian, K. C., Davis, J. C., Merrill, J. T., Totoritis, M. C., Wofsy, D., & for the IDEC‐131 Lupus Study Group (2002) · Arthritis & Rheumatism · doi:10.1002/art.10681 · Cited by 336
Schönbeck, U., Mach, F., Sukhova, G. K., Murphy, C., Bonnefoy, J.-Y., Fabunmi, R. P., & Libby, P. (1997) · Circulation Research · doi:10.1161/01.res.81.3.448 · Cited by 334
Self-citationCD40 Is Constitutively Expressed on Platelets and Provides a Novel Mechanism for Platelet Activation
Inwald, D. P., McDowall, A., Peters, M. J., Callard, R. E., & Klein, N. J. (2003) · Circulation Research · doi:10.1161/01.res.0000070111.98158.6c · Cited by 333
Fibrosis of the Lung and Other Tissues: New Concepts in Pathogenesis and Treatment
Sime, P. J., & O'Reilly, K. M. A. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5008 · Cited by 330
T Cell Replicative Senescence in Human Aging
P. Chou, J., & B. Effros, R. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805219711 · Cited by 323
Nomura, S., Tandon, N. N., Nakamura, T., Cone, J., Fukuhara, S., & Kambayashi, J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00433-6 · Cited by 304
Vella, J. P., Spadafora-Ferreira, M., Murphy, B., Alexander, S. I., Harmon, W., Carpenter, C. B., & Sayegh, M. H. (1997) · Transplantation · doi:10.1097/00007890-199709270-00001 · Cited by 293
Modulation of NF-κB Activity and Apoptosis in Chronic Lymphocytic Leukemia B Cells
Furman, R. R., Asgary, Z., Mascarenhas, J. O., Liou, H.-C., & Schattner, E. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2200 · Cited by 278
The Influence of Human Immunodeficiency Virus-1 on Hematopoiesis
Moses, A., Nelson, J., & Bagby, G. C. (1998) · Blood · doi:10.1182/blood.v91.5.1479 · Cited by 277
Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
Lutgens, E., Cleutjens, K. B. J. M., Heeneman, S., Koteliansky, V. E., Burkly, L. C., & Daemen, M. J. A. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7464 · Cited by 271
The role of inflammation in vascular diseases
Sullivan, G. W., Sarembock, I. J., & Linden, J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.5.591 · Cited by 271
Hermann, A., Rauch, B. H., Braun, M., Schrör, K., & Weber, A.-A. (2001) · Platelets · doi:10.1080/09537100020031207 · Cited by 255
Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice
Tan, J., Town, T., Crawford, F., Mori, T., DelleDonne, A., Crescentini, R., Obregon, D., Flavell, R. A., & Mullan, M. J. (2002) · Nature Neuroscience · doi:10.1038/nn968 · Cited by 217
“Vascular endothelial and smooth muscle cells express CD4”
BackgroundNeuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease
Farfara, D., Lifshitz, V., & Frenkel, D. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00314.x · Cited by 216
Oxidative risk for atherothrombotic cardiovascular disease
Leopold, J. A., & Loscalzo, J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.09.009 · Cited by 215
Lougaris, V., Badolato, R., Ferrari, S., & Plebani, A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00229.x · Cited by 195
Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients
Sidiropoulos, P. I., & Boumpas, D. T. (2004) · Lupus · doi:10.1191/0961203304lu1032oa · Cited by 178
Burysek, L., Syrovets, T., & Simmet, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201941200 · Cited by 168
CD40/CD40L signaling and its implication in health and disease
Chatzigeorgiou, A., Lyberi, M., Chatzilymperis, G., Nezos, A., & Kamper, E. (2009) · BioFactors · doi:10.1002/biof.62 · Cited by 164
“CD40/CD40L interaction stimulates cells to produce and secrete cytokines and chemokines, to express adhesion molecules, costimulating molecules and enzymes, such as matrix metalloproteinases (MMPs), all of which are involved in the local inflammatory processes that take place in many chronic inflammatory diseases [1,8…”
BackgroundCancer immunotherapy: activating innate and adaptive immunity through CD40 agonists
Beatty, G. L., Li, Y., & Long, K. B. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1270208 · Cited by 163
Xia, M., Ling, W., Zhu, H., Wang, Q., Ma, J., Hou, M., Tang, Z., Li, L., & Ye, Q. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000254672.04573.2d · Cited by 96
Tan, J., Town, T., & Mullan, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002006200 · Cited by 67
Metadata
- Authors
- Mach, F., Schönbeck, U., Sukhova, G. K., Bourcier, T., Bonnefoy, J.-Y., Pober, J. S., & Libby, P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-03-04
- Volume
- 94
- Issue
- 5
- Pages
- 1931-1936
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2004680931
- Cited by
- 732
- References
- 35
- FWCI
- 16.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.